Geraldine O'Sullivan Coyne

9PUBLICATIONS
81CO-AUTHORS
Animal systematics and taxonomyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

|Jan 08, 2026
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim, Karla V Ballman, Pamela L Wolters

|Jul 16, 2025
Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid Tumors.

Geraldine O'Sullivan Coyne, Khanh T Do, Shivaani Kummar

|Mar 19, 2025
A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors.

Sarah J Shin, Geraldine O'Sullivan Coyne, Shivaani Kummar

|Oct 27, 2022
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma.

James Nguyen, Naoko Takebe, Shivaani Kummar

|Oct 30, 2021
Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas.

Geraldine O'Sullivan Coyne, Shivaani Kummar, James Hu

Pageof 2

Frequent Collaborators

7 joint publications

James H Doroshow

6 joint publications

Alice P Chen

4 joint publications

Naoko Takebe

4 joint publications

Lawrence Rubinstein